MX2021006057A - Uso de una defensina vegetal para inhibir la infeccion de un patogeno fungico. - Google Patents
Uso de una defensina vegetal para inhibir la infeccion de un patogeno fungico.Info
- Publication number
- MX2021006057A MX2021006057A MX2021006057A MX2021006057A MX2021006057A MX 2021006057 A MX2021006057 A MX 2021006057A MX 2021006057 A MX2021006057 A MX 2021006057A MX 2021006057 A MX2021006057 A MX 2021006057A MX 2021006057 A MX2021006057 A MX 2021006057A
- Authority
- MX
- Mexico
- Prior art keywords
- humans
- animals
- fungal infection
- keratin
- present disclosure
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 abstract 3
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 102000011782 Keratins Human genes 0.000 abstract 2
- 108010076876 Keratins Proteins 0.000 abstract 2
- 208000031888 Mycoses Diseases 0.000 abstract 2
- 208000010195 Onychomycosis Diseases 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000005882 tinea unguium Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
La presente divulgación se refiere al control de infecciones fúngicas de las envolturas córneas que cubren las falanges dorsales y terminales de humanos y animales y protrusiones cerebrales relacionadas de los animales, y también de material que comprende queratina sobre las superficies de humanos y animales. También son abarcados por la presente divulgación agentes, formulaciones y extractos naturales y sintéticos útiles para el control de infecciones fúngicas de estas envolturas, protrusiones relacionadas y material que comprende queratina. En una modalidad, la presente divulgación enseña el tratamiento de infecciones fúngicas de las uñas y, en particular, la onicomicosis en humanos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462066808P | 2014-10-21 | 2014-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021006057A true MX2021006057A (es) | 2021-07-06 |
Family
ID=55748162
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017005305A MX2017005305A (es) | 2014-10-21 | 2015-05-29 | Un metodo de tratamiento. |
MX2021006057A MX2021006057A (es) | 2014-10-21 | 2017-04-21 | Uso de una defensina vegetal para inhibir la infeccion de un patogeno fungico. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017005305A MX2017005305A (es) | 2014-10-21 | 2015-05-29 | Un metodo de tratamiento. |
Country Status (23)
Country | Link |
---|---|
US (4) | US9713632B2 (es) |
EP (2) | EP3949977A1 (es) |
JP (3) | JP6646662B2 (es) |
KR (1) | KR102472312B1 (es) |
CN (2) | CN107106647B (es) |
AU (2) | AU2015336933B2 (es) |
BR (1) | BR112017008211A2 (es) |
CA (1) | CA2965187A1 (es) |
CY (1) | CY1124640T1 (es) |
DK (1) | DK3209319T3 (es) |
ES (1) | ES2890461T3 (es) |
HR (1) | HRP20211477T8 (es) |
HU (1) | HUE056178T2 (es) |
LT (1) | LT3209319T (es) |
MX (2) | MX2017005305A (es) |
MY (1) | MY186552A (es) |
NZ (1) | NZ731143A (es) |
PL (1) | PL3209319T3 (es) |
PT (1) | PT3209319T (es) |
RS (1) | RS62386B1 (es) |
SG (2) | SG10201912688YA (es) |
SI (1) | SI3209319T1 (es) |
WO (1) | WO2016061619A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9573980B2 (en) | 2013-03-15 | 2017-02-21 | Spogen Biotech Inc. | Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots |
WO2015161348A1 (en) * | 2014-04-24 | 2015-10-29 | Hexima Limited | Agents and methods of treatment |
BR122023020829A2 (pt) | 2014-09-17 | 2024-01-23 | Spogen Biotech Inc. | Bactéria recombinante formadora de esporos, sua formulação, e semente de planta revestida com as mesmas |
DK3209319T3 (da) * | 2014-10-21 | 2021-10-04 | Hexima Ltd | En fremgangsmåde til behandling af svampeinfektioner |
SG11201708815UA (en) * | 2015-05-29 | 2017-12-28 | Hexima Ltd | A method of in vivo treatment |
US20190275078A1 (en) * | 2018-03-09 | 2019-09-12 | Therazure LLC | Compositions for the treatment of infections in feet |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3298368A (en) | 1964-04-24 | 1967-01-17 | Charos Peter | Heated cream applicator gloves |
US4087675A (en) | 1977-02-07 | 1978-05-02 | Coretta Sansonetti | Heated mitten |
US4241080A (en) * | 1979-05-29 | 1980-12-23 | The Dow Chemical Company | Stabilized aqueous antimicrobial composition |
US4267852A (en) | 1979-09-17 | 1981-05-19 | Hullinger Judith E | Process for enhancing and strengthening the growth of nails |
JPS5775663A (en) | 1980-07-22 | 1982-05-12 | Kiichirou Sarui | Apparatus for treating dermatophytosis |
US5181914A (en) | 1988-08-22 | 1993-01-26 | Zook Gerald P | Medicating device for nails and adjacent tissue |
US5219877A (en) | 1989-09-25 | 1993-06-15 | Bristol-Myers Squibb Company | Lauryl alcohol as skin penetration enhancer for topical imidazole agents |
US5098415A (en) | 1990-10-09 | 1992-03-24 | Jack Levin | Device and method for using an aqueous solution containing ozone to treat foot diseases |
US5156591A (en) | 1990-12-13 | 1992-10-20 | S. I. Scientific Innovations Ltd. | Skin electrode construction and transdermal drug delivery device utilizing same |
JPH0657323A (ja) | 1992-08-06 | 1994-03-01 | Sumitomo Metal Ind Ltd | 加熱炉におけるバーナー制御方法 |
JPH0728521A (ja) | 1993-07-09 | 1995-01-31 | Yaskawa Electric Corp | シミュレーションプログラム自動作成方法 |
US5449658A (en) | 1993-12-07 | 1995-09-12 | Zeneca, Inc. | Biocidal compositions comprising polyhexamethylene biguanide and EDTA, and methods for treating commercial and recreational water |
US5696164A (en) | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
US5668084A (en) | 1995-08-01 | 1997-09-16 | Zeneca Inc. | Polyhexamethylene biguanide and surfactant composition and method for preventing waterline residue |
US5795314A (en) | 1996-06-19 | 1998-08-18 | Berenstein; Moshe | Therapeutic fingernail treatment device |
TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
US5981698A (en) * | 1997-06-03 | 1999-11-09 | Cyberchemics, Inc. | Antimicrobial polypeptides |
US5993790A (en) * | 1997-08-04 | 1999-11-30 | Pedinol Pharmacal Inc. | Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections |
WO1999009997A1 (en) * | 1997-08-26 | 1999-03-04 | Board Of Regents, The University Of Texas System | Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
US6727401B1 (en) | 1998-02-12 | 2004-04-27 | Watson Pharmaceuticals, Inc. | Pressure sensitive adhesive matrix patch for the treatment of onychomycosis |
US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
US6235047B1 (en) | 1998-04-06 | 2001-05-22 | Augustine Medical, Inc. | Wound treatment apparatus with a heater, a heat conductive bandage, and heat-spreading means acting between the heater and bandage |
US6572580B2 (en) | 1998-08-06 | 2003-06-03 | Profoot, Inc. | Set depth nail notcher with patch system and method for treating nail fungus |
US6159977A (en) | 1998-11-16 | 2000-12-12 | Astan, Inc. | Therapeutic anti-fungal nail preparation |
US6477410B1 (en) | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
AU6076200A (en) | 1999-07-08 | 2001-01-30 | Johnson & Johnson Consumer Companies, Inc. | Exothermic bandage |
US6528697B1 (en) | 2000-01-03 | 2003-03-04 | Augustine Medical, Inc. | Modular bandage |
US6281239B1 (en) | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
AU2002229407C1 (en) * | 2001-02-08 | 2005-09-01 | Hexima Limited | Plant-derived molecules and genetic sequences encoding same and uses therefor |
US6585963B1 (en) | 2001-02-15 | 2003-07-01 | Watson Pharmaceuticals, Inc. | Nail compositions and methods of administering same |
EP1393628A4 (en) | 2001-06-08 | 2007-11-14 | Ki Chemical Industry Co Ltd | MICROORGANISMS KILL THE LIQUID DESODORING AGENT AND PROCESS FOR MICROORGANISM KILLING DESODORATION |
EP2270185A3 (en) * | 2001-06-22 | 2012-04-04 | Pioneer Hi-Bred International, Inc. | Defensin polynucleotides and methods of use |
US6821508B2 (en) | 2001-06-27 | 2004-11-23 | Rutgers, The State University | Composition and method for topical nail treatment |
JP2003123136A (ja) | 2001-10-17 | 2003-04-25 | Toshiba Electric Appliance Co Ltd | 飲料提供装置 |
US20030144625A1 (en) | 2002-01-28 | 2003-07-31 | Garry Sherman | Method and apparatus for the treatment of infections of the nail matrix and nail plate |
US6634367B2 (en) | 2002-03-25 | 2003-10-21 | Kathleen Hunter Abraham | Sealing enclosure for finger tips |
US6846837B2 (en) | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
CN1678277B (zh) | 2002-07-29 | 2010-05-05 | 艾克里麦德公司 | 治疗皮肤病的方法和组合物 |
US6921529B2 (en) | 2002-07-29 | 2005-07-26 | Joseph C. Maley | Treatment modality and method for fungal nail infection |
US20070292355A1 (en) | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US20040161452A1 (en) | 2003-02-18 | 2004-08-19 | Petit Michael G. | Drug-dispensing dressing and composition for treating onychomycosis |
KR20060033795A (ko) | 2003-07-14 | 2006-04-19 | 파워 페이퍼 리미티드 | 물질의 동전기적 운반을 이용한 손발톱진균증 치료를 위한방법, 기구 및 키트 |
US20050261755A1 (en) | 2004-05-24 | 2005-11-24 | Bacino John E | Conformable heat transfer pack |
US20060013862A1 (en) | 2004-07-19 | 2006-01-19 | Held Jerry M | Onychomycosis: a new process for cure |
JP2006075357A (ja) | 2004-09-09 | 2006-03-23 | Institute Of Physical & Chemical Research | 水虫の治療装置 |
PL2987796T3 (pl) | 2005-02-16 | 2018-12-31 | Anacor Pharmaceuticals, Inc. | Fluorowco-podstawione boronoftalidy do leczenia zakażeń |
WO2006125092A2 (en) | 2005-05-18 | 2006-11-23 | Tyrell, Inc. | Treatment device and method for treating skin lesions through application of heat |
US7793666B2 (en) | 2005-07-28 | 2010-09-14 | Innovation Biomedical Devices, Inc. | Apparatus and method for treatment of infected nail |
US20070104664A1 (en) | 2005-10-26 | 2007-05-10 | California Institute Of Technology | Treatment of toenail fungus |
RU2008131324A (ru) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
CA2651212A1 (en) | 2006-05-02 | 2007-11-15 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
JP2010529897A (ja) | 2007-06-15 | 2010-09-02 | ニトリツク・バイオ・セラピユーテイクス・インコーポレーテツド | 動電学的薬剤配送の電流集中緩和方法とシステム |
US20090048590A1 (en) | 2007-08-15 | 2009-02-19 | Tyrell, Inc. | Systems and methods for treating nail-bed fungus through application of heat |
ES2324192B1 (es) * | 2008-01-30 | 2010-06-17 | PUIG BEAUTY & FASHION GROUP, S.L. | Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas. |
FR2942716B1 (fr) * | 2009-03-06 | 2011-04-15 | Galderma Res & Dev | Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle |
IT1395241B1 (it) | 2009-08-07 | 2012-09-05 | Iarrera | Apparato per la germinazione controllata di semi e relativo metodo. |
EP2544659A2 (en) | 2009-12-23 | 2013-01-16 | Nuvo Research Inc. | Highly permeating terbinafine formulation for treating onychomycosis |
BR112013003223A2 (pt) * | 2010-08-23 | 2016-06-07 | Pioneer Hi Bred Int | "polinucleotídeo isolado, cassete de expressão, célula hospedeira, micro-organismo, planta ou parte de planta, método de obtenção de uma planta transformada, composição antipatogênica, método para proteger uma planta contra um patógeno ou uso de um polinucleotídeo isolado" |
KR101311196B1 (ko) * | 2010-12-23 | 2013-09-27 | 중앙대학교 산학협력단 | 진균 감염 또는 뇌수막염 치료를 위한 upr 신호전달 유전자 ire1 및 hxl1의 용도 |
CN107648341A (zh) * | 2010-12-28 | 2018-02-02 | 卡梅迪斯有限公司 | 用于治疗和预防感染的植物提取物 |
EP2664327A1 (en) | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
AR094821A1 (es) | 2012-07-25 | 2015-09-02 | Hanmi Pharm Ind Co Ltd | Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada |
JP6457945B2 (ja) * | 2012-11-23 | 2019-01-23 | ヘキシマ リミテッドHexima Limited | 抗病原体方法 |
AU2013260696A1 (en) * | 2012-11-23 | 2014-06-12 | Hexima Limited | Use of anti-fungal defensins |
WO2014142102A1 (ja) | 2013-03-12 | 2014-09-18 | 大日本住友製薬株式会社 | 液体水性組成物 |
JP2017519720A (ja) | 2014-04-23 | 2017-07-20 | ヘキシマ リミテッド | 病原体の治療のための薬剤および方法 |
WO2015161348A1 (en) | 2014-04-24 | 2015-10-29 | Hexima Limited | Agents and methods of treatment |
DK3209319T3 (da) | 2014-10-21 | 2021-10-04 | Hexima Ltd | En fremgangsmåde til behandling af svampeinfektioner |
-
2015
- 2015-05-29 DK DK15852021.3T patent/DK3209319T3/da active
- 2015-05-29 SG SG10201912688YA patent/SG10201912688YA/en unknown
- 2015-05-29 JP JP2017522540A patent/JP6646662B2/ja active Active
- 2015-05-29 CN CN201580066874.XA patent/CN107106647B/zh not_active Expired - Fee Related
- 2015-05-29 BR BR112017008211A patent/BR112017008211A2/pt active Search and Examination
- 2015-05-29 HR HRP20211477TT patent/HRP20211477T8/hr unknown
- 2015-05-29 US US14/726,400 patent/US9713632B2/en active Active
- 2015-05-29 LT LTEPPCT/AU2015/050293T patent/LT3209319T/lt unknown
- 2015-05-29 MX MX2017005305A patent/MX2017005305A/es unknown
- 2015-05-29 ES ES15852021T patent/ES2890461T3/es active Active
- 2015-05-29 EP EP21185003.7A patent/EP3949977A1/en not_active Withdrawn
- 2015-05-29 SI SI201531699T patent/SI3209319T1/sl unknown
- 2015-05-29 CN CN202110640986.9A patent/CN113368215A/zh active Pending
- 2015-05-29 SG SG11201703184SA patent/SG11201703184SA/en unknown
- 2015-05-29 WO PCT/AU2015/050293 patent/WO2016061619A1/en active Application Filing
- 2015-05-29 KR KR1020177013649A patent/KR102472312B1/ko active IP Right Grant
- 2015-05-29 RS RS20211133A patent/RS62386B1/sr unknown
- 2015-05-29 MY MYPI2017701333A patent/MY186552A/en unknown
- 2015-05-29 HU HUE15852021A patent/HUE056178T2/hu unknown
- 2015-05-29 AU AU2015336933A patent/AU2015336933B2/en active Active
- 2015-05-29 PT PT158520213T patent/PT3209319T/pt unknown
- 2015-05-29 PL PL15852021T patent/PL3209319T3/pl unknown
- 2015-05-29 EP EP15852021.3A patent/EP3209319B1/en active Active
- 2015-05-29 CA CA2965187A patent/CA2965187A1/en active Pending
- 2015-05-29 NZ NZ731143A patent/NZ731143A/en not_active IP Right Cessation
-
2017
- 2017-04-21 MX MX2021006057A patent/MX2021006057A/es unknown
- 2017-04-21 US US15/494,400 patent/US10973874B2/en active Active
- 2017-06-01 US US15/610,853 patent/US10010576B2/en active Active
-
2019
- 2019-11-13 JP JP2019205104A patent/JP6990224B2/ja active Active
-
2021
- 2021-03-02 US US17/190,013 patent/US11446354B2/en active Active
- 2021-03-23 AU AU2021201810A patent/AU2021201810A1/en active Pending
- 2021-09-21 CY CY20211100827T patent/CY1124640T1/el unknown
- 2021-12-03 JP JP2021196576A patent/JP7207780B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021006057A (es) | Uso de una defensina vegetal para inhibir la infeccion de un patogeno fungico. | |
PH12017501033A1 (en) | Oral care compositions and methods of use | |
EP3510993A4 (en) | COSMETIC COMPOSITION FOR SKIN CARE | |
EP3661538A4 (en) | COMPOSITIONS AND METHODS FOR IMPROVING LAXITY OF THE SKIN AND THE CONTOUR OF THE BODY | |
EA201792450A1 (ru) | Матирующие косметические композиции | |
MX2017008813A (es) | Polvo de coleopteros. | |
EP3269356A4 (en) | Cosmetic composition for whitening skin and preparation method thereof | |
EP3300731A4 (en) | HAIR-REPAIRING / GROWTH-STIMULATING ACTIVE AGENT | |
EP3694339A4 (en) | IMPROVED FEEDING COMPOSITIONS AND METHODS OF USE | |
EP3600224A4 (en) | SKIN CARE COMPOSITIONS CONSISTING OF A TERPOLYMER AND PROCESS FOR THE PREPARATION AND METHOD OF USE OF THE LATTER | |
MX2016009241A (es) | Metodos para reducir el mal olor y las bacterias. | |
EP3377084A4 (en) | COMPOSITIONS CONTAINING NATURAL EXTRACTS AND THEIR USE FOR SKIN AND HAIR | |
MX2014009750A (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
EP3687491A4 (en) | HAIR CARE COMPOSITIONS AND METHODS | |
MX2022002635A (es) | Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso. | |
TW201613977A (en) | Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use | |
EP3700539A4 (en) | METHOD OF IMPROVING THE RECOVERY OF A SKIN TREATED WITH A COSMETIC LASER | |
EP3503866A4 (en) | COMPOSITIONS AND METHODS FOR RESTORING EPIDERMIS INTEGRITY AND FUNCTION, AND FOR TREATING DERMATOLOGICAL DISEASES | |
BR112017023316A2 (pt) | método cosmético e uso terapêutico para redução de gordura | |
MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. | |
EP3664773A4 (en) | HAIR TREATMENT COMPOSITIONS AND PROCEDURES | |
MX2017010670A (es) | Alimento en forma de gel para lechoncillos, metodo para manufacturar el mismo y uso. | |
PH12016501448A1 (en) | Antifungal composition | |
GB201611406D0 (en) | Skin care composition and method thereof | |
MX2018015570A (es) | Composicion cosmetica anti-envejecimiento, uso de la composicion y metodo para tratamiento anti-envejecimiento. |